(ALB) Albemarle - Overview
Stock: Lithium, Bromine, Catalysts
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.05% |
| Yield on Cost 5y | 1.03% |
| Yield CAGR 5y | 0.95% |
| Payout Consistency | 97.3% |
| Payout Ratio | 58.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 57.7% |
| Relative Tail Risk | -1.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.47 |
| Alpha | 90.46 |
| Character TTM | |
|---|---|
| Beta | 1.673 |
| Beta Downside | 1.521 |
| Drawdowns 3y | |
|---|---|
| Max DD | 81.98% |
| CAGR/Max DD | -0.16 |
Description: ALB Albemarle January 06, 2026
Albemarle Corp (NYSE:ALB) operates three core segments: Energy Storage, which manufactures lithium compounds (carbonate, hydroxide, chloride) for EV batteries, consumer electronics, grid-scale storage and recycling services; Specialties, which produces bromine-based chemicals, high-purity lithium reagents, and specialty metals for fire safety, pharmaceuticals and pyrotechnics; and Ketjen, which supplies hydroprocessing, FCC and isomerization catalysts for clean-fuel and petrochemical applications across automotive, aerospace, and industrial markets.
Key data points to watch: as of Q4 2023 Albemarle reported a 14% YoY increase in lithium-ion battery-grade lithium carbonate production, driven by a 30% surge in EV sales worldwide; its adjusted EBITDA margin hovered around 30%, reflecting strong pricing power amid lithium price volatility; and the company’s net debt-to-EBITDA ratio stands near 1.2×, indicating moderate leverage. The primary macro driver is the rapid expansion of global EV adoption, projected to raise lithium demand by ~20% annually through 2028, while bromine demand is closely tied to fire-safety regulations and the growth of specialty chemicals in the pharma sector.
For a deeper, data-rich assessment of ALB’s valuation and risk profile, explore the detailed analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -21.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 8.69 > 1.0 |
| NWC/Revenue: 51.57% < 20% (prev 42.43%; Δ 9.14% < -1%) |
| CFO/TA 0.05 > 3% & CFO 894.5m > Net Income -21.2m |
| Net Debt (1.83b) to EBITDA (722.9m): 2.53 < 3 |
| Current Ratio: 2.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (117.7m) vs 12m ago 0.13% < -2% |
| Gross Margin: 12.31% > 18% (prev -0.12%; Δ 1243 % > 0.5%) |
| Asset Turnover: 28.59% > 50% (prev 37.25%; Δ -8.66% > 0%) |
| Interest Coverage Ratio: 0.33 > 6 (EBITDA TTM 722.9m / Interest Expense TTM 194.6m) |
Altman Z'' 2.70
| A: 0.15 (Total Current Assets 4.55b - Total Current Liabilities 2.00b) / Total Assets 17.15b |
| B: 0.30 (Retained Earnings 5.12b / Total Assets 17.15b) |
| C: 0.00 (EBIT TTM 64.9m / Avg Total Assets 17.30b) |
| D: 0.69 (Book Value of Equity 4.75b / Total Liabilities 6.88b) |
| Altman-Z'' Score: 2.70 = A |
Beneish M -3.22
| DSRI: 1.09 (Receivables 841.2m/1.02b, Revenue 4.95b/6.50b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.94 (AQ_t 0.19 / AQ_t-1 0.20) |
| SGI: 0.76 (Revenue 4.95b / 6.50b) |
| TATA: -0.05 (NI -21.2m - CFO 894.5m) / TA 17.15b) |
| Beneish M-Score: -3.22 (Cap -4..+1) = AA |
What is the price of ALB shares?
Over the past week, the price has changed by -4.05%, over one month by +24.98%, over three months by +85.32% and over the past year by +113.78%.
Is ALB a buy, sell or hold?
- StrongBuy: 6
- Buy: 3
- Hold: 17
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the ALB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 165.1 | -8.7% |
| Analysts Target Price | 165.1 | -8.7% |
| ValueRay Target Price | 205.6 | 13.8% |
ALB Fundamental Data Overview January 24, 2026
P/S = 4.481
P/B = 2.7307
P/EG = 11.2537
Revenue TTM = 4.95b USD
EBIT TTM = 64.9m USD
EBITDA TTM = 722.9m USD
Long Term Debt = 3.18b USD (from longTermDebt, last quarter)
Short Term Debt = 474.5m USD (from shortTermDebt, last quarter)
Debt = 3.76b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.83b USD (from netDebt column, last quarter)
Enterprise Value = 24.00b USD (22.16b + Debt 3.76b - CCE 1.93b)
Interest Coverage Ratio = 0.33 (Ebit TTM 64.9m / Interest Expense TTM 194.6m)
EV/FCF = 230.1x (Enterprise Value 24.00b / FCF TTM 104.3m)
FCF Yield = 0.43% (FCF TTM 104.3m / Enterprise Value 24.00b)
FCF Margin = 2.11% (FCF TTM 104.3m / Revenue TTM 4.95b)
Net Margin = -0.43% (Net Income TTM -21.2m / Revenue TTM 4.95b)
Gross Margin = 12.31% ((Revenue TTM 4.95b - Cost of Revenue TTM 4.34b) / Revenue TTM)
Gross Margin QoQ = 8.99% (prev 14.80%)
Tobins Q-Ratio = 1.40 (Enterprise Value 24.00b / Total Assets 17.15b)
Interest Expense / Debt = 1.35% (Interest Expense 51.0m / Debt 3.76b)
Taxrate = 21.0% (US default 21%)
NOPAT = 51.2m (EBIT 64.9m * (1 - 21.00%))
Current Ratio = 2.27 (Total Current Assets 4.55b / Total Current Liabilities 2.00b)
Debt / Equity = 0.38 (Debt 3.76b / totalStockholderEquity, last quarter 10.00b)
Debt / EBITDA = 2.53 (Net Debt 1.83b / EBITDA 722.9m)
Debt / FCF = 17.57 (Net Debt 1.83b / FCF TTM 104.3m)
Total Stockholder Equity = 10.06b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.12% (Net Income -21.2m / Total Assets 17.15b)
RoE = -0.21% (Net Income TTM -21.2m / Total Stockholder Equity 10.06b)
RoCE = 0.49% (EBIT 64.9m / Capital Employed (Equity 10.06b + L.T.Debt 3.18b))
RoIC = 0.45% (NOPAT 51.2m / Invested Capital 11.40b)
WACC = 10.48% (E(22.16b)/V(25.93b) * Re(12.08%) + D(3.76b)/V(25.93b) * Rd(1.35%) * (1-Tc(0.21)))
Discount Rate = 12.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.14%
[DCF Debug] Terminal Value 59.94% ; FCFF base≈104.3m ; Y1≈68.5m ; Y5≈31.2m
Fair Price DCF = N/A (negative equity: EV 429.8m - Net Debt 1.83b = -1.40b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -79.79 | EPS CAGR: -20.68% | SUE: 0.86 | # QB: 2
Revenue Correlation: -18.45 | Revenue CAGR: 10.67% | SUE: 0.19 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=+0.360 | Revisions Net=+3 | Analysts=6
EPS next Year (2026-12-31): EPS=2.29 | Chg30d=+1.206 | Revisions Net=+6 | Growth EPS=+372.4% | Growth Revenue=+16.6%